T-Therapeutics names Theodora Harold as new CEO
Portfolio - People | Mar 18, 2025 | Sofinnova Partners
T-Therapeutics, a biotechnology company focused on next-generation soluble T cell receptor therapeutics, has appointed Theodora Harold as its new CEO. Formerly with Crescendo Biologics, Harold brings over 25 years of experience in the biotech sector, with a history of effective leadership and capital raising. Theodora’s appointment comes as the company transitions into the development phase of its assets, following its $60 million Series A fundraise in late 2023. Founder Allan Bradley will assume the role of Chief Scientific Officer. T-Therapeutics aims to leverage its OpTiMus platform to address novel TCR targets with potential applications in cancer and autoimmune disorders.
Sectors
- Biotechnology
- Pharmaceuticals
Geography
- United Kingdom – T-Therapeutics is located in Cambridge, England, making the United Kingdom the primary geography in this article.
Industry
- Biotechnology – The article is about T-Therapeutics, a company in the biotechnology industry, focusing on developing therapeutics targeting cancer and autoimmune diseases.
- Pharmaceuticals – The development of therapeutics for cancer and autoimmune diseases aligns with the pharmaceutical sector.
Financials
- 60,000,000 – T-Therapeutics' Series A fundraise amount at the end of 2023.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Theodora Harold | New CEO | People | Newly appointed Chief Executive Officer of T-Therapeutics, bringing extensive biotech experience. |
| T-Therapeutics | Target Company | Company | A biotechnology company developing next-generation soluble T cell receptor therapeutics. |
| Allan Bradley | Chief Scientific Officer | People | Founder and former CEO of T-Therapeutics, transitioning to the role of Chief Scientific Officer. |
| Sofinnova Partners | PE Firm | Company | Private equity firm associated with T-Therapeutics, potentially a major funder. |
| Crescendo Biologics | Former Employer | Company | Previous employer of Theodora Harold, demonstrating her prior CEO experience. |
| ICR Consilium | PR Advisor | Company | Public relations company providing communication services for T-Therapeutics. |
| David Hung | Chairman | People | Chairman of T-Therapeutics board, supporting Theodora’s appointment. |